Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Shockwave Medical, Inc. - Common Stock (NQ: SWAV )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Shockwave Medical, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
2 Beaten-Down Growth Stocks to Buy Now Before They Start Soaring Again
After falling 73% and 38% from their previous peaks, these beaten-down growth stocks are trading at sensible valuations. 
Via The Motley Fool
5 Analysts Have This to Say About ShockWave Medical
Via Benzinga
Shockwave Medical Just Tripled Profit Expectations, Delivering 991% Growth
The company also beat sales expectations, meeting the high end of its outlook. 
Via Investor's Business Daily
Shockwave Medical Shares Gain As Q4 Earnings Surpass Wall Street Expectations
Via Benzinga
ShockWave Medical (SWAV) Q4 2022 Earnings Call Transcript
SWAV earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Shockwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Shockwave Medical, Inc.
Via GlobeNewswire
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
ShockWave Medical's Earnings Outlook
Via Benzinga
Where ShockWave Medical Stands With Analysts
Via Benzinga
ShockWave Medical Earnings Perspective: Return On Capital Employed
Via Benzinga
3 Mid-Cap Earnings Plays to Watch This Week
Mid-caps could continue to be the hot hand for traders and investors alike. Keep an eye on these three upcoming earnings reports. 
Via MarketBeat
Topics Economy
Exposures Economy
Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status
Guidance Expands Number of Hospitals that Can Access IVL to Include Sites Where Calcium Modification Tools Were Previously Not Recommended 
From Shockwave Medical, Inc.
Via GlobeNewswire
3 Pharma Stocks That Will Mint Millionaires
These pharma stocks all have excellent risk-reward ratios and the companies have developed treatments that could easily become blockbusters. 
Via InvestorPlace
Mergers and Acquisitions in 2023 Off To A Strong Start
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road. 
Via MarketBeat
Exposures Product Safety
3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023
These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses. 
Via The Motley Fool
Neovasc (NASDAQ: NVCN) (TSX: NVCN) Enters into Agreement to be Acquired by Shockwave Medical (NASDAQ: SWAV) for $100 Million & CVR
Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) is engaged as a specialty medical device company, which is focused on the development, 
Via Spotlight Growth
Exposures Product Safety
Why Neovasc Shares Are Trading Higher Today
Neovasc Inc. (NASDAQ: NVCN) shares are trading higher after ShockWave Medical, Inc. (NASDAQ: SWAV) announced it would acquire the company. 
Via Benzinga
Shockwave Medical Seeks To Bolster Its Cardiovascular Disease Portfolio With Neovasc Acquisition
Via Benzinga
Shockwave Medical Announces Agreement to Acquire Neovasc
From Shockwave Medical, Inc.
Via GlobeNewswire
How Doug Godshall Ignited The Spark At Shockwave
ShockWave Medical CEO Doug Godshall says successful companies don't follow a formula. 
Via Investor's Business Daily
Shockwave Medical Provides Quarterly Earnings Release Dates for 2023
From Shockwave Medical, Inc.
Via GlobeNewswire
2 Elite Growth Stocks Ready for a Bull Run in 2023
It's going to take more than a recession to stop these two from delivering outsized gains to patient investors. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
Nasdaq Bear Market: 3 Unstoppable Growth Stocks to Buy at Knocked-Down Prices
The road ahead of these businesses is a lot smoother than you'd think by looking at their stock prices. 
Via The Motley Fool
7 Index Funds to Buy to Retire a Millionaire
Although the market shows signs of improvement, the waters are still choppy enough for investors to focus on index funds to buy. 
Via InvestorPlace
3 Beaten-Down Growth Stocks That Billionaires Are Buying With Both Hands
Some of the world's most successful investors can't get enough of The Trade Desk, Shockwave Medical, and SoFi Technologies. 
Via The Motley Fool
Shockwave Medical to Participate in the Piper Sandler 34th Annual Healthcare Conference
From Shockwave Medical, Inc.
Via GlobeNewswire
$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years
Long-term investors should consider the high upside of these growth stocks. 
Via The Motley Fool
InMode Stock Shows Improved Technical Strength; Hits Key Technical Threshold
The Relative Strength (RS) Rating for InMode stock moved up into a higher percentile Wednesday, as it got a lift from 64 to 78. 
Via Investor's Business Daily
Shockwave Medical Publishes Inaugural ESG Report
From Shockwave Medical, Inc.
Via GlobeNewswire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.